Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged uspto · clear
Written by Nathanael Luman, Ph.D. and Scott Raevsky The USPTO Director granted a request to extend a missed deadline for an appeal of an IPR decision to the Federal Circuit due to the patent owner’s excusable neglect in Mitsubishi Cable Industr.,…
Written by Kerry S. Taylor , Ph.D. The USPTO’s Patent Trial and Appeal Board (PTAB) has released its March 2017 statistics. The end of March marking the halfway point in the USPTO's fiscal year, the overall totals for fiscal year 2017 (FY 2017)…
In a previous post , in reaction to Apple’s game of branding hide-and-seek, I introduced the idea of a delay in initial publication of new U.S. trademark applications. As brief background, in March 2014 Apple filed a trademark application for the…
Written by Nathanael Luman , Ph.D. and Kerry S. Taylor, Ph.D. The PTAB granted-in-part motions to amend in three related proceedings: Activision Blizzard, Inc. v. Acceleration Bay, LLC, IPR2015-01953, Paper 107 (P.T.A.B. sealed on March 23, 2017, made…
Technical Findings of PTAB Increasingly Leveraged in Parallel Court Proceedings Patent challenge proceedings of the USPTO's Patent Trial & Appeal Board (PTAB) are designed to provide a low cost, expedited option to district court litigation. Of course,…
In tomorrow's Federal Register , the USPTO is announcing a public symposium on issues relevant to the protection of trade secrets, and to assess recent developments such as the Defend Trade Secrets Act (DTSA). The symposium will be held on May 8, 2017,…
PTAB Procedural Reform Initiative Today the USPTO announced its PTAB Procedural Reform Inititative . The initiative seeks feedback on the nearly five years of historical data and user experiences to further shape and improve Patent Trial and Appeal Board…
With its seminal patents and continual patent enforcement activity, hybrid vehicle technology company Paice has been a frequent subject of discussion in this space. In fact, my first post almost ten years ago was about the company’s litigation with…
Written by Rebecca L. Wright , Ph.D. and Jonathan Hyman Edited by Loni Morrow and Catherine Holland Airwair, the owner of the Dr. Martens brand, recently launched a series of lawsuits in the Northern District of California to enforce the trade dress of its…
Last month, the Federal Circuit issued its opinion in Shire Development v. Watson Pharmaceuticals, finding that Watson’s generic version of LIALDA® did not infringe U.S. patent 6,773,720 (“the ‘720 patent”). In particular, the…
Couple of weeks ago we reported that Zond ranked first among patent owners with 125 IPR challenges filed against 10 of its patents. This week we delved into the claim-level analysis of these IPR cases. A total of 371 unique claims had been challenged, and…
Written by Jonathan Menkes and Catherine Holland Edited by Loni Morrow and Jonathan Hyman Under U.S. trademark law, any person (including a celebrity) can obtain a trademark registration for their name if they can establish that the public recognizes the…
